Starting Dose of Metoprolol for Palpitations
For managing palpitations, initiate metoprolol tartrate at 25 mg orally twice daily, which can be titrated up to a maximum of 100 mg twice daily based on symptom control and tolerability. 1
Initial Dosing Strategy
- Start with metoprolol tartrate 25 mg twice daily for symptomatic palpitations, as this provides adequate beta-blockade while minimizing risk of adverse effects 1
- For patients with concerns about beta-blocker tolerance (such as mild reactive airway disease or borderline blood pressure), consider starting even lower at 12.5 mg twice daily 1
- The extended-release formulation (metoprolol succinate) can be initiated at 50 mg once daily if preferred for convenience, with a maximum dose of 400 mg daily 1
Titration Protocol
- Increase the dose gradually every 1-2 weeks if palpitations persist and the patient tolerates the initial dose well 1
- Target a resting heart rate of 50-60 beats per minute unless limiting side effects occur 1
- For metoprolol tartrate, titrate from 25 mg to 50 mg twice daily, then up to the maximum of 100 mg twice daily as needed 1
Critical Contraindications to Screen Before Prescribing
Before initiating metoprolol for palpitations, you must rule out:
- AV block greater than first degree or SA node dysfunction 1
- Decompensated heart failure or signs of low cardiac output 1
- Severe asthma or active reactive airway disease (though mild COPD or history of wheezing is not an absolute contraindication at reduced doses) 1
- Hypotension (systolic BP <100 mmHg) 1
- Cardiogenic shock or risk factors for it 1
Special Considerations for Specific Arrhythmias
If palpitations are due to atrial fibrillation, the dosing is similar but may require higher doses:
- Start with 25-100 mg twice daily of metoprolol tartrate 2, 1
- Alternatively, use metoprolol succinate 50-200 mg once daily for rate control 2
- In acute settings with rapid ventricular response, IV metoprolol 2.5-5 mg over 2 minutes can be given, repeated every 5 minutes up to 15 mg total, then transition to oral therapy 2
Monitoring Parameters
- Check heart rate and blood pressure at each follow-up visit 1
- Watch for symptomatic bradycardia (HR <60 bpm with dizziness) or hypotension (systolic BP <100 mmHg with symptoms) 1
- Listen for bronchospasm, particularly in patients with any history of reactive airway disease 1
- Assess for delayed adverse effects like fatigue or weakness, which may appear within 2-3 weeks 1
Common Pitfalls to Avoid
- Do not abruptly discontinue metoprolol once started, as this can cause severe exacerbation of angina, myocardial infarction, and ventricular arrhythmias 1
- Avoid metoprolol in pre-excited atrial fibrillation (Wolff-Parkinson-White syndrome), as it can paradoxically accelerate ventricular rate by blocking the AV node and facilitating conduction down the accessory pathway 2
- Do not combine with other AV nodal blocking agents without careful monitoring, as profound bradycardia can develop 3
- For patients with mild wheezing or COPD history, use a reduced dose (12.5-25 mg) rather than completely avoiding beta-blockers 1
Expected Outcomes
- Clinical response may be delayed and require 2-3 months to become fully apparent 1
- Most patients with palpitations from benign arrhythmias respond well to doses in the 50-100 mg twice daily range 1
- Note that for idiopathic frequent PVCs, beta-blockers may be less effective, with good response seen in only 11-16% of patients, and paradoxical worsening can occur in up to 25% 4